In January 2019, the Company was approached by China Prosper Group, an investment management and advisory 

company, expressing a strong interest on behalf of its investor clients in purchasing the DenseLight fabrication facility 

in Singapore. The Company took this offer seriously for several reasons, including the potential investors’ financial 

strength, their interest in investing in both R&D and high-volume manufacturing capacity for InP-based devices, and 

the Company’s desire to invest more of its limited resources in Optical Interposer-based solutions versus supporting 

the continuous need for capital expenses typical of any semiconductor manufacturing operation. China Prosper Group

also expressed the intention of its group of investors, which eventually organized into the Consortium, to support 

DenseLight’s losses until it achieved and exceeded cash break-even operations.